Core Viewpoint - The company has repurchased a total of 197,500 shares, representing 0.17% of its current total share capital, as part of its share buyback plan [1] Summary by Categories Share Buyback Details - The repurchase was conducted through a dedicated securities account via centralized bidding [1] - The highest transaction price was 16.05 CNY per share, while the lowest was 13.15 CNY per share [1] - The total amount spent on the repurchase was 3.0299 million CNY, excluding transaction fees [1] Compliance and Future Plans - The repurchase complies with relevant laws and regulations, as well as the company's share buyback plan requirements [1] - The company intends to continue implementing the buyback plan within the designated timeframe and will fulfill its information disclosure obligations promptly [1]
共同药业：累计回购0.17%公司股份